The Bio Report

563 Episoder

1. Why Big Pharma Hasn’t Been Able to Fix Its Revenue Gap with M&A

   Udgivet: 22.1.2015
2. Remembering Industry Pioneer Ron Cape

   Udgivet: 15.1.2015
3. Moving from Chronic Therapies to Cures

   Udgivet: 8.1.2015
4. What’s in Store for the Biotech Industry in 2015

   Udgivet: 31.12.2014
5. A Look at the Year That Was in Biotech

   Udgivet: 24.12.2014
6. Why Privacy Concerns May Limit Big Data’s Payoff

   Udgivet: 18.12.2014
7. Calculating the Cost of Drug Development and What it Means

   Udgivet: 11.12.2014
8. How New Funding Models Are Accelerating Drug Development

   Udgivet: 4.12.2014
9. Telemedicine Grows, but Reimbursement Remains an Obstacle

   Udgivet: 28.11.2014
10. The Power of IBM’s Watson Is Coming to an App Near You

    Udgivet: 20.11.2014
11. Brittany Maynard and the Debate over the Right to Die

    Udgivet: 13.11.2014
12. What’s Driving the Booming Market for Orphan Drugs

    Udgivet: 6.11.2014
13. Why Interoperability Is Much More than a Technology Problem

    Udgivet: 30.10.2014
14. The Lean Startup Takes Hold in the Life Sciences

    Udgivet: 23.10.2014
15. Enlisting Monoclonal Antibodies to Combat Bacterial Resistance

    Udgivet: 16.10.2014
16. The Forces Bringing Disruptive Change to Healthcare

    Udgivet: 9.10.2014
17. How One Foundation is Getting the Biggest Bang for Its R&D Bucks

    Udgivet: 2.10.2014
18. International Collaboration Seeks to Drive Breakthroughs in Progressive MS

    Udgivet: 24.9.2014
19. Will Increased FDA Regulation of Diagnostics Speed or Slow Development of Personalized Medicine

    Udgivet: 18.9.2014
20. Using Human Biology to Improve R&D

    Udgivet: 11.9.2014